What do you think of the concept of "dysuricemia" - the concept that both hyperuricemia and hypouricemia influence diseases. “The lower, the better” is incorrect; the ideal is to maintain normouricemia, or optimal SU level, to reduce the urate burden https://t.co/vYSNzWuPVW https://t.co/tde3Mh6Wij

• Dysuricemia

Do We Stop or Continue Treatment? Remission had been a dream, an elusive concept. But then, with the introduction of biologics, conventional synthetic and targeted synthetic DMARDS, patients are able to live longer and with a better quality of life. https://t.co/2ecihSwGIV https://t.co/rAjHvlyMB8

• Do We Stop or Continue Treatment? | RheumNow

WATCH: TMP SMX Prophylaxis in GPA https://t.co/VEkGFUewjG https://t.co/HouepsLEuw https://t.co/r1kiXejFQn

• TMP SMX Prophylaxis in GPA | RheumNow
• https://bit.ly/46BbYFL

The SMART Study: Split Dose Oral Methotrexate Dr. Jack Cush discusses abstract 1583 presented at the 2023 ACR Convergence meeting in San Diego. https://t.co/STybvwt9N5 https://t.co/BTwstJiFHr https://t.co/vfb2A5zZAp

• The SMART Study: Split Dose Oral Methotrexate | RheumNow
• https://bit.ly/49V39cy

Biologics as First-line Therapy for PMR and GCA? Dr. Eric Dein talks with Dr. Philip Seo, one of two panelists for the Great Debate: Should PMR and GCA Be Treated with Advanced Therapies at Disease Onset? https://t.co/eezZkBr8x7 https://t.co/D0dTSkjsNS https://t.co/nBlFyKNkHM

• Biologics as First-line Therapy for PMR and GCA? | RheumNow
• https://bit.ly/46AA8QA

Can Rheumatologists Accurately Diagnose axSpA in Patients w/Chronic Back Pain? Chronic low back pain is a common complaint that patients bring to the doctor’s attention. https://t.co/dnlRtjsUHl https://t.co/wQq1J4Iudf https://t.co/24dQSWlwdr

• Can Rheumatologists Accurately Diagnose axSpA in Patients with Chronic Back Pai…
• https://bit.ly/3uDyHUd

"Protein kinases: drug targets for immunological disorders". Great full-read review from J Shea et al. Reviews Hx, biology, clinical use and safetey of Kinase targeted therapy. https://t.co/T4qMZG2DLI https://t.co/xANcLeiGr6 https://t.co/wAknXuvjl4

• Protein kinases: drug targets for immunological disorders
• https://bit.ly/47U1enr

Check out this engaging video exploring the pathophysiology and management of gout flares. https://t.co/wgxUIkdJ7v https://t.co/kWRGXfPeYz

• Gout Flares: Taking a Deeper Look | RheumNow

Early bird pricing has been extended! Register today! https://t.co/DSyFGlEJZx https://t.co/T0QoRCn3tK

• RN Live - RheumNow

PR3+ in Lupus Nephritis https://t.co/rLdlAQYCfT https://t.co/CzLotVPwlh

• PR3+ in Lupus Nephritis | RheumNow

Check out this engaging video exploring the pathophysiology and management of gout flares. https://t.co/LNmXZyDec1 https://t.co/nKojprg9mU

• Gout Flares: Taking a Deeper Look | RheumNow

Next generation JAK-inhibition strategies As there are many JAK-inhibitors evaluated in clinical trials currently, how do you stand out? https://t.co/Pm6cCK5ltN https://t.co/h9z3nku1gZ

• Next generation JAK-inhibition strategies | RheumNow

UKs MHRA issued a safety alert #MTX maybe associated w/ photosensitivity. Based on Coroners death (by secondary infx) report assoc w/ photosensitivity Rxn in a MTX Rx pt. Warning is because this is not a well-known side effect https://t.co/Vbl9BYMMNC https://t.co/9SyYQMTXTl https://t.co/JNqvNieqrt

• Safety update: methotrexate and photosensitivity reactions
• Methotrexate: advise patients to take precautions in the sun to avoid photosens…